|
|
Please
login
to be able to add spectra, identifiers, links and publications.
Aspirin, also known as acetylsalicylic acid (ASA), (), is a salicylate drug, often used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication.
Aspirin also has an antiplatelet or "anti-clotting" effect and is used in long-term, low doses to prevent heart attacks, strokes and blood clot formation in people at high risk for developing blood clots. It has also been established that low doses of aspirin may be given immediately after a heart attack to reduce the risk of another heart attack or of the death of cardiac tissue.
The main undesirable side effects of aspirin are gastrointestinal— ulcers and stomach bleeding—and tinnitus, especially in higher doses. In children under 19 years of age, aspirin is no longer used to control flu-like symptoms or the symptoms of chickenpox, due to the risk of Reye's syndrome.
Aspirin was the first-discovered member of the class of drugs known as non-steroidal anti-inflammatory drugs (NSAIDs), not all of which are salicylates, although they all have similar effects and most have some mechanism of action which involves non-selective inhibition of the enzyme cyclooxygenase. Today, aspirin is one of the most widely used medications in the world, with an estimated 40,000 metric tons of it being consumed each year. In countries where Aspirin is a registered trademark owned by Bayer, the generic term is acetylsalicylic acid (ASA).
Read more... or Edit at Wikipedia...
User Data
- experimental physchem properties
- miscellaneous
Validated by Experts, Validated by Users, Non-Validated, Removed by Users,
Redirected by Users, Redirect Approved by Experts
11126-35-5
[RN]
11126-37-7
[RN]
2-(Acetyloxy)benzolcarbonsäure
2349-94-2
[RN]
26914-13-6
[RN]
98201-60-6
[RN]
A.S.A.
Acesan
Acetard
Acetoxybenzoic acid
More...
Acetyl-SAL
Acetyonyl
Acetysalicylic acid
acide 2-(acétyloxy)benzoïque
Acide acetylsalicylique
Acido acetilsalicilico
[Italian]
Asatard
Aspirin
[Wiki]
Aspirin (JP15/USP)
Aspirin (VAN)
Aspropharm
Benzoic acid, 2-(acetyloxy)-
Cardioaspirina
Doril
Melhoral
Miniasal
o-(Acetyloxy)benzoic Acid
Rhodine NC RP
Salicylic acid, acetyl-
Salospir
Tasprin
Toldex
Triaminicin
2-(Acetyloxy)benzoic acid
200-064-1
[EINECS/ELINCS]
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
4-10-00-00138
[Beilstein]
50-78-2
[RN]
Acenterine
Acesal
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
acetol
Acetophen
Acetosal
Acetosalic acid
Acetosalin
acetyl salicylic acid
Acetylin
Acetylsal
Acetylsalicylate
[Wiki]
ACETYLSALICYLIC ACID
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalycilic acid
Acetysal
Acido O-acetil-benzoico
[Italian]
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
AIN
Anacin
[Wiki]
Anacin Maximum Strength
Arthritis Pain Formula Maximum Strength
ASA
Asagran
Ascriptin
Aspec
Aspergum
[Wiki]
Aspirdrops
Aspirin [BAN:JAN]
Aspirina 03
Aspirine
[Wiki]
Aspro
[Wiki]
Aspro Clear
Asteric
AXOTAL
[Wiki]
Azetylsalizylsaeure
Bayer
[Wiki]
Bayer Aspirin 8 Hour
Bayer Buffered
Bayer Children's Aspirin
Bayer Enteric 325 mg Regular Strength
Bayer Enteric 81 mg Adult Low Strength
Bayer Plus
Benaspir
Benzoic acid, 2- (acetyloxy)-
Bialpirina
Bialpirinia
Bi-prin
Bufferin
[Wiki]
Caprin
Cemirit
Claradin
Clariprin
Colfarit
Contrheuma retard
Crystar
Decaten
Delgesic
Duramax
[Wiki]
Easprin
Easprin (TN)
ECM
Ecolen
Ecotrin
Empirin
Empirin with Codeine
Endosprin
Endydol
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
EQUAGESIC
[Wiki]
Extren
Globentyl
Globoid
Helicon
[Wiki]
Idragin
Istopirin
Kapsazal
Kyselina 2-acetoxybenzoova
[Czech]
Kyselina acetylsalicylova
[Czech]
Levius
MEASURIN
[Wiki]
Medisyl
Micristin
Novid
o-Acetoxybenzoic acid
O-Acetylsalicylic acid
o-Carboxyphenyl acetate
PERCODAN
[Wiki]
Persistin
Pharmacin
Pirseal
Polopiryna
Pravigard PAC
Premaspin
PROPOXYPHENE COMPOUND 65
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
ROBAXISAL
rodine
Ronal
Salacetin
Salcetogen
Saletin
Salicylic acid acetate
Salicylic acid, acetate
Solfrin
Solprin
Solprin acid
Solpyron
SOMA COMPOUND
Spira-Dine
St. Joseph Aspirin for Adults
Supac
Synalgos
Temperal
Triple-sal
Vanquish
[Wiki]
Xaxa
Yasta
Zorprin
Less...
Validated by Experts, Validated by Users, Non-Validated, Removed by Users,
Redirected by Users, Redirect Approved by Experts
|
LogP: |
ACD/LogP:
1.19
XLogP:
1.40
ALOGPS:
1.43
|
# of Rule of 5 Violations: |
0
|
|
ACD/LogD (pH 5.5): |
-0.8
|
ACD/LogD (pH 7.4): |
-1.89
|
|
ACD/BCF (pH 5.5): |
1
|
ACD/BCF (pH 7.4): |
1
|
|
ACD/KOC (pH 5.5): |
1.08
|
ACD/KOC (pH 7.4): |
1
|
|
#H bond acceptors: |
4
|
#H bond donors: |
1
|
|
#Freely Rotating Bonds: |
3
|
Polar Surface Area: |
52.6
Å2
|
|
Index of Refraction: |
1.55
|
Molar Refractivity: |
44.52
cm3
|
|
Molar Volume: |
139.5
cm3
|
Polarizability: |
17.65
10-24cm3
|
|
Surface Tension: |
49.8
dyne/cm
|
Density: |
1.29
g/cm3
|
|
Flash Point: |
131.2
°C
|
Enthalpy of Vaporization: |
59.45
kJ/mol
|
|
Boiling Point: |
321.4
°C at 760 mmHg
|
Vapour Pressure: |
0.000124
mmHg at 25°C
|
Log Octanol-Water Partition Coef (SRC):
Log Kow (KOWWIN v1.67 estimate) = 1.13
Log Kow (Exper. database match) = 1.19
Exper. Ref: Hansch,C et al. (1995)
Boiling Pt, Melting Pt, Vapor Pressure Estimations (MPBPWIN v1.42):
Boiling Pt (deg C): 315.88 (Adapted Stein & Brown method)
Melting Pt (deg C): 93.06 (Mean or Weighted MP)
VP(mm Hg,25 deg C): 6.56E-005 (Modified Grain method)
MP (exp database): 135 deg C
VP (exp database): 2.52E-05 mm Hg at 25 deg C
Subcooled liquid VP: 0.000309 mm Hg (25 deg C, exp database VP )
Water Solubility Estimate from Log Kow (WSKOW v1.41):
Water Solubility at 25 deg C (mg/L): 5295
log Kow used: 1.19 (expkow database)
no-melting pt equation used
Water Sol (Exper. database match) = 4600 mg/L (25 deg C)
Exper. Ref: YALKOWSKY,SH & DANNENFELSER,RM (1992)
Water Sol Estimate from Fragments:
Wat Sol (v1.01 est) = 11196 mg/L
Wat Sol (Exper. database match) = 4600.00
Exper. Ref: YALKOWSKY,SH & DANNENFELSER,RM (1992)
ECOSAR Class Program (ECOSAR v0.99h):
Class(es) found:
Esters-acid
Henrys Law Constant (25 deg C) [HENRYWIN v3.10]:
Bond Method : 1.30E-009 atm-m3/mole
Group Method: Incomplete
Exper Database: 1.30E-09 atm-m3/mole
Henrys LC [VP/WSol estimate using EPI values]: 2.937E-009 atm-m3/mole
Log Octanol-Air Partition Coefficient (25 deg C) [KOAWIN v1.10]:
Log Kow used: 1.19 (exp database)
Log Kaw used: -7.275 (exp database)
Log Koa (KOAWIN v1.10 estimate): 8.465
Log Koa (experimental database): None
Probability of Rapid Biodegradation (BIOWIN v4.10):
Biowin1 (Linear Model) : 1.0128
Biowin2 (Non-Linear Model) : 0.9990
Expert Survey Biodegradation Results:
Biowin3 (Ultimate Survey Model): 3.0291 (weeks )
Biowin4 (Primary Survey Model) : 3.8245 (days )
MITI Biodegradation Probability:
Biowin5 (MITI Linear Model) : 0.9301
Biowin6 (MITI Non-Linear Model): 0.9379
Anaerobic Biodegradation Probability:
Biowin7 (Anaerobic Linear Model): 0.8122
Ready Biodegradability Prediction: YES
Hydrocarbon Biodegradation (BioHCwin v1.01):
Structure incompatible with current estimation method!
Sorption to aerosols (25 Dec C)[AEROWIN v1.00]:
Vapor pressure (liquid/subcooled): 0.0412 Pa (0.000309 mm Hg)
Log Koa (Koawin est ): 8.465
Kp (particle/gas partition coef. (m3/ug)):
Mackay model : 7.28E-005
Octanol/air (Koa) model: 7.16E-005
Fraction sorbed to airborne particulates (phi):
Junge-Pankow model : 0.00262
Mackay model : 0.00579
Octanol/air (Koa) model: 0.0057
Atmospheric Oxidation (25 deg C) [AopWin v1.92]:
Hydroxyl Radicals Reaction:
OVERALL OH Rate Constant = 1.3068 E-12 cm3/molecule-sec
Half-Life = 8.185 Days (12-hr day; 1.5E6 OH/cm3)
Half-Life = 98.222 Hrs
Ozone Reaction:
No Ozone Reaction Estimation
Fraction sorbed to airborne particulates (phi): 0.00421 (Junge,Mackay)
Note: the sorbed fraction may be resistant to atmospheric oxidation
Soil Adsorption Coefficient (PCKOCWIN v1.66):
Koc : 10
Log Koc: 1.000
Aqueous Base/Acid-Catalyzed Hydrolysis (25 deg C) [HYDROWIN v1.67]:
Total Kb for pH > 8 at 25 deg C : 1.306E+000 L/mol-sec
Kb Half-Life at pH 8: 6.143 days
Kb Half-Life at pH 7: 61.430 days
Bioaccumulation Estimates from Log Kow (BCFWIN v2.17):
Log BCF from regression-based method = 0.500 (BCF = 3.162)
log Kow used: 1.19 (expkow database)
Volatilization from Water:
Henry LC: 1.3E-009 atm-m3/mole (Henry experimental database)
Half-Life from Model River: 6.045E+005 hours (2.519E+004 days)
Half-Life from Model Lake : 6.595E+006 hours (2.748E+005 days)
Removal In Wastewater Treatment:
Total removal: 1.91 percent
Total biodegradation: 0.09 percent
Total sludge adsorption: 1.82 percent
Total to Air: 0.00 percent
(using 10000 hr Bio P,A,S)
Level III Fugacity Model:
Mass Amount Half-Life Emissions
(percent) (hr) (kg/hr)
Air 0.0285 196 1000
Water 32.8 360 1000
Soil 67.1 720 1000
Sediment 0.0689 3.24e+003 0
Persistence Time: 621 hr
Descriptors:
0, 0, 0, 1, 0, 0, 0, 5, 1, 0, 0, 0, 3, 4, 0, 0, 6, 4, 2, 0, 0, 0, 0, 0
| Category | Target | PDB Code | LASSO Score |
| Metalloenzymes | ACE, angiotensin-converting enzyme; | 1o86 | 0.04 |
| Other Enzymes | AChE, acetylcholinesterase; | 1eve | 0.00 |
| Metalloenzymes | ADA, adenosine deaminase; | 1stw | 0.00 |
| Other Enzymes | ALR2, aldose reductase; | 1ah3 | 0.00 |
| Other Enzymes | AmpC, AmpC beta-lactamase; | 1xgj | 0.01 |
| Nuclear Hormone Receptors | AR, androgen receptor; | 1xq2 | 0.00 |
| Kinases | CDK2, cyclindependent kinase 2; | 1ckp | 0.00 |
| Metalloenzymes | COMT, catechol O-methyltransferase; | 1h1d | 0.00 |
| Other Enzymes | COX-1, cyclooxygenase-1; | 1p4g | 0.78 |
| Other Enzymes | cyclooxygenase-2 | 1cx2 | 0.00 |
| Folate Enzymes | DHFR, dihydrofolate reductase; | 3dfr | 0.00 |
| Kinases | EGFr, epidermal growth factor receptor; | 1m17 | 0.00 |
| Nuclear Hormone Receptors | ER, estrogen receptor; agonist | 1l2i | 0.00 |
| Nuclear Hormone Receptors | ER, estrogen receptor; antagonist | 3ert | 0.01 |
| Kinases | FGFr1, fibroblast growth factor receptor kinase; | 1agw | 0.00 |
| Serine Proteases | FXa, factor Xa; | 1f0r | 0.01 |
| Folate Enzymes | GART, glycinamide ribonucleotide transformylase; | 1c2t | 0.00 |
| Other Enzymes | GPB, glycogen phosphorylase â; | 1a8i | 0.00 |
| Other Enzymes | HIVPR, HIV protease; | 1hpx | 0.00 |
| Other Enzymes | HIVRT, HIV reverse transcriptase; | 1rt1 | 0.00 |
| Other Enzymes | HMGR, hydroxymethylglutaryl-CoA reductase; | 1hw8 | 0.01 |
| Kinases | HSP90, human heat shock protein 90; | 1uy6 | 0.00 |
| Other Enzymes | InhA, enoyl ACP reductase; | 1p44 | 0.00 |
| Nuclear Hormone Receptors | MR, mineralocorticoid receptor; | 2aa2 | 0.01 |
| Other Enzymes | NA, neuraminidase; | 1a4g | 0.04 |
| Kinases | P38 MAP, P38 mitogen activated protein; | 1kv2 | 0.00 |
| Other Enzymes | PARP, poly(ADP-ribose) polymerase; | 1efy | 0.03 |
| Kinases | PDGFrb, platelet derived growth factor receptor kinase; | | 0.00 |
| Other Enzymes | PNP, purine nucleoside phosphorylase; | 1b8o | 0.00 |
| Nuclear Hormone Receptors | PPARg, peroxisome proliferator activated receptor ç; | 1fm9 | 0.08 |
| Nuclear Hormone Receptors | PR, progesterone receptor; | 1sr7 | 0.00 |
| Nuclear Hormone Receptors | RXRa, retinoic X receptor R; | 1mvc | 0.00 |
| Other Enzymes | SAHH, S-adenosyl-homocysteine hydrolase; | 1a7a | 0.00 |
| Kinases | SRC, tyrosine kinase SRC; | 2src | 0.01 |
| Serine Proteases | Thrombin | 1ba8 | 0.00 |
| Kinases | TK, thymidine kinase; | 1kim | 0.00 |
| Kinases | VEGFr2, vascular endothelial growth factor receptor; | 1vr2 | 0.00 |
Comments: These data were collected from standards supplied by legitimate manufacturers or synthesized in forensic laboratories under controlled conditions. Supplied by John Meyers, Member of the ChemSpider Advisory Group.
| |